Ahmed Monjur
Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, USA.
Can J Gastroenterol Hepatol. 2025 Aug 13;2025:6210421. doi: 10.1155/cjgh/6210421. eCollection 2025.
Gastrointestinal fistulas are increasingly being encountered in our clinical practice because of the increased burden of Crohn's disease, bariatric surgeries, interventional endoscopic procedures, nonsurgical trauma, and war and disaster zones worldwide. Presentation depends on the location and specific type of the fistula. Symptomatic ones can have a tremendous impact on social life and can cause dehydration, electrolyte imbalance, malnutrition, increased morbidity, and mortality. Different imaging studies and endoscopic procedures are done to establish the diagnosis. Treatment modalities to close the fistula depend on the underlying disease and the type of fistula. They include conservative treatment, medical therapy, endoscopic interventions, and surgery. Currently, there is no accepted treatment algorithm due to a lack of controlled clinical trials. The prognosis varies from fistula to fistula, and the mortality can be as high as 50%.
由于克罗恩病负担增加、减肥手术、介入性内镜手术、非手术创伤以及全球范围内的战争和灾区,胃肠道瘘在我们的临床实践中越来越常见。临床表现取决于瘘管的位置和具体类型。有症状的瘘管会对社交生活产生巨大影响,并可导致脱水、电解质失衡、营养不良、发病率增加和死亡率上升。通过不同的影像学检查和内镜检查来确立诊断。闭合瘘管的治疗方式取决于基础疾病和瘘管类型。这些治疗方式包括保守治疗、药物治疗、内镜干预和手术。目前,由于缺乏对照临床试验,尚无公认的治疗方案。不同瘘管的预后各不相同,死亡率可高达50%。